封面
市场调查报告书
商品编码
1945820

植物药和针灸市场-全球产业规模、份额、趋势、机会和预测:干预方法、分销方法、区域和竞争格局,2021-2031年

Botanicals & Acupuncture Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Intervention (Botanicals, Acupuncture), By Distribution Method, By Region & Competition, 2021-2031F

出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球草药和针灸市场预计将从 2025 年的 448.2 亿美元大幅成长到 2031 年的 733.2 亿美元,复合年增长率为 8.55%。

该领域涵盖植物来源疗法和传统针灸疗法的商业化和应用,旨在实现整体健康管理。市场扩张的主要驱动力是全球慢性病盛行率的不断上升,以及消费者对非侵入性、预防性医疗保健方案的明显偏好,这些方案旨在最大程度地减少对合成药物的依赖。人口老化也进一步推动了这一趋势,人们希望透过整合医学来延年益寿。美国植物委员会 (ABC) 的报告支持了这一增长,该报告称,预计到 2024 年,美国草药膳食补充剂的零售额将达到创纪录的 132.3 亿美元,比上一年增长 5.4%。

市场概览
预测期 2027-2031
市场规模:2025年 448.2亿美元
市场规模:2031年 733.2亿美元
复合年增长率:2026-2031年 8.55%
成长最快的细分市场 针刺
最大的市场 欧洲

然而,市场扩张的一大障碍是各国缺乏统一的法规结构和品管标准。植物产品的核准流程和针灸师的执业许可要求各不相同,这严重阻碍了国际贸易和人才流动。这种监管碎片化使得跨国公司难以进入市场,可能损害消费者对产品安全性和有效性的信心,并限制了永续产业发展所需的普遍可及性。

市场驱动因素

慢性病发病率的上升以及对非药物镇痛疗法日益增长的需求,正在从根本上改变全球植物疗法和针灸市场。随着医疗服务提供者和患者都在寻求替代鸦片类药物和合成止痛药的疗法来治疗骨关节炎和肌肉骨骼疾病等,实证治疗方法(如针灸)正迅速普及。这种趋势的动力源于人们对低风险、有效且符合整体护理框架的干预措施的需求。例如,美国国家补充与综合健康中心2024年1月发布的报告《美国成年人补充健康疗法总体使用情况及疼痛管理使用情况》显示,美国成年人使用针灸的比例在20年间增长了一倍多,到2022年达到2.2%。其中,针灸用于疼痛管理的使用者成长尤其显着。

同时,随着消费者对预防性保健和洁净标示疗法的兴趣日益浓厚,他们越来越倾向于选择天然和有机保健产品,市场也因此持续扩张。这一趋势体现在消费者对植物来源成分而非传统药物的偏好不断增强,从而提升了植物萃取物和膳食补充剂的商业性前景。根据责任营养委员会 (CRN) 于 2024 年 10 月发布的《2024 年消费者调查》数据,自 2020 年以来,植物补充剂睡茄的使用量增长了四倍,目前占膳食补充剂消费者的 8%。此外,全球基础设施建设也在稳步推进。 2024 年 8 月,世界卫生组织 (WHO) 宣布,印度政府承诺向全球传统医学中心提供 8,500 万美元的资金,凸显了该领域的国际发展。

市场挑战

国际上不同司法管辖区的法规结构和品管标准存在差异,这仍然是全球草药疗法和针灸市场发展的主要障碍。这种不一致性造成了营运摩擦,阻碍了业界建立统一的全球标准。对于草药疗法生产者而言,应对不同的核准流程增加了遵循成本,并扰乱了供应链。同时,针灸师执业许可规则的不一致阻碍了人才流动和治疗通讯协定的标准化。这些不一致导致潜在消费者产生疑虑,他们可能认为缺乏统一的监管会对产品的安全性和有效性构成威胁,从而有效地抑制了消费者对产品的信任,而信任是产品被大规模接受所必需的。

此外,监管不统一限制了这些疗法融入主流医疗体系,阻碍了全民普及。缺乏标准化的核准导致保险覆盖范围狭窄,患者高度依赖自付费用,这使得许多人远离医疗保健。美国国家针灸及东方医学认证委员会(NBOCM)的报告凸显了这个问题,报告指出,由于行政程序和报销方面的挑战,到2024年,仅有45%的针灸从业者接受保险。这项数据表明,监管障碍和支付方接受度的不一致直接限制了该行业的扩张,有效地抑制了其发展,即便全球对整体医疗保健的兴趣日益增长。

市场趋势

全球草药和针灸市场正经历着重大变革时期,草药产品正朝着直接面向消费者的电子商务模式转型,这从根本上改变了通路。消费者越来越倾向于选择提供教育内容和个人化订阅服务的数位平台,以获得专业的植物配方。这种数位化提高了原料来源的透明度,并使得数据分析能够应用于开发针对特定健康益处(例如认知增强)的产品。美国植物委员会 (ABC) 于 2025 年 9 月发布的《2024 年草药市场报告》也印证了这一管道的主导地位。报告预测,直接面向消费者的销售额将引领整个零售市场,总值将达到 75 亿美元(年成长 6.8%)。

同时,将针灸和植物疗法融入养生旅游套餐,正在创造新的高价值商机。豪华度假村和饭店业者正将传统中医和阿育吠陀疗法融入生物骇客和长寿疗养计画中,提供超越单纯放鬆的实证復健护理。这种融合吸引了追求积极健康优化和身临其境型整体体验而非被动医疗干预的富裕旅行者。全球健康研究所于2025年12月发布的《2025年全球健康经济监测报告》反映了这一强劲的需求,预测到2029年,传统和补充医学产业将以每年10.8%的速度成长,显着超过整体经济成长趋势。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章:客户评价

第五章 全球植物成分及针灸市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依治疗方法(植物疗法(阿育吠陀、自然疗法、同类疗法)、针灸)
    • 依分销方式(直销、电子销售、邮购)
    • 按地区
    • 按公司(2025 年)
  • 市场地图

第六章 北美植物成分及针灸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲:国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲植物成分及针灸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲:国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区植物成分及针灸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:中东和非洲植物成分及针灸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲:国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章:南美洲植物成分及针灸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲:国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球植物成分及针灸市场:SWOT分析

第十四章:波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Modern Acupuncture
  • Chiropuncture, Inc.
  • ARC Acupuncture & Physical Therapy
  • NatureKue, Inc.
  • Columbia Nutritional, LLC
  • Herb Pharm
  • HILLS HERBAL CARE
  • Pure Encapsulations Inc
  • Ayush Ayurveda
  • SHENG CHANG PHARMACEUTICAL CO., LTD.

第十六章 策略建议

第十七章:关于研究公司及免责声明

简介目录
Product Code: 19537

The Global Botanicals & Acupuncture Market is projected to expand significantly, growing from a valuation of USD 44.82 Billion in 2025 to USD 73.32 Billion by 2031, representing a compound annual growth rate of 8.55%. This sector comprises the commercial trade and utilization of plant-based therapeutic agents and traditional needle-stimulation therapies designed for holistic health management. Market expansion is largely driven by the increasing global prevalence of chronic diseases and a distinct consumer preference for non-invasive, preventive healthcare options that minimize dependence on synthetic drugs. This trend is further bolstered by an aging population seeking functional longevity through integrative medicine. Underscoring this growth, the American Botanical Council reported that retail sales of herbal dietary supplements in the United States hit a record $13.23 billion in 2024, marking a 5.4% rise from the prior year.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 44.82 Billion
Market Size 2031USD 73.32 Billion
CAGR 2026-20318.55%
Fastest Growing SegmentAcupuncture
Largest MarketEurope

Conversely, a major obstacle hindering widespread market growth is the lack of consistent regulatory frameworks and quality control standards among different nations. Discrepancies in approval processes for botanical goods and differing licensure prerequisites for acupuncture professionals establish significant hurdles to seamless international trade and workforce mobility. This regulatory fragmentation makes market entry difficult for multinational entities and risks eroding consumer trust in product safety and effectiveness, thereby limiting the universal accessibility needed for sustained industry development.

Market Driver

The growing incidence of chronic conditions and the intensified search for non-pharmacological pain relief are fundamentally transforming the Global Botanicals & Acupuncture Market. As healthcare providers and patients alike look for alternatives to opioids and synthetic painkillers for ailments like osteoarthritis and musculoskeletal issues, evidence-based treatments such as acupuncture are seeing rapid uptake. This adoption is fueled by a demand for low-risk, effective interventions that fit within holistic care frameworks. Illustrating this shift, a January 2024 report by the National Center for Complementary and Integrative Health titled 'Use of Complementary Health Approaches Overall and for Pain Management by US Adults' revealed that acupuncture usage among U.S. adults more than doubled over two decades, reaching 2.2% in 2022, with a significant number of users specifically seeking pain management.

Concurrently, the market is expanding due to a rising consumer inclination toward natural and organic healthcare products, driven by an interest in preventative wellness and clean-label therapeutics. This movement involves a growing preference for plant-based ingredients over conventional medicines, boosting the commercial prospects of botanical extracts and supplements. Data from the Council for Responsible Nutrition's '2024 Consumer Survey,' released in October 2024, indicates that the use of the botanical supplement Ashwagandha has quadrupled since 2020, now being used by 8% of all supplement consumers. Additionally, global infrastructure is being bolstered; in August 2024, the World Health Organization noted that the Government of India pledged US$ 85 million to the Global Traditional Medicine Centre, underscoring the sector's expanding international scale.

Market Challenge

The disparity in regulatory frameworks and quality control standards across various international jurisdictions remains a central obstacle for the Global Botanicals & Acupuncture Market. This lack of uniformity causes operational friction and prevents the industry from establishing cohesive global norms. For manufacturers of botanicals, dealing with differing approval processes raises compliance expenses and interrupts supply chains, while inconsistent licensure rules for acupuncturists hinder workforce mobility and the standardization of treatment protocols. Such inconsistency generates skepticism among prospective consumers, who may view the lack of unified oversight as a threat to product safety and effectiveness, effectively stifling the trust needed for mass adoption.

Moreover, the absence of regulatory harmonization restricts the integration of these therapies into mainstream financial healthcare systems, thereby limiting universal access. Without standardized recognition, reimbursement options are narrow, leading to a heavy dependence on out-of-pocket payments that alienate large segments of the population. Highlighting this issue, the National Certification Commission for Acupuncture and Oriental Medicine reported in 2024 that only 45% of acupuncture practitioners accepted insurance due to administrative and reimbursement difficulties. This figure demonstrates how regulatory barriers and inconsistent payer acceptance directly limit the sector's expansion, effectively curbing growth despite increasing global interest in holistic health management.

Market Trends

The Global Botanicals & Acupuncture Market is undergoing a significant transformation toward direct-to-consumer e-commerce models for herbal products, which is fundamentally changing distribution channels. Consumers are increasingly skipping traditional retail stores in favor of digital platforms that provide educational content and personalized subscription services for specialized botanical formulas. This shift to digital allows for improved transparency regarding ingredient sourcing and enables brands to use data analytics for product development targeted at specific health outcomes, such as cognitive performance. Underscoring the dominance of this channel, the American Botanical Council's '2024 Herb Market Report' from September 2025 indicated that direct-to-consumer sales topped all retail segments, totaling $7.5 billion and marking a 6.8% rise from the prior year.

At the same time, the incorporation of acupuncture and botanicals into wellness tourism packages is creating new, high-value revenue opportunities. Luxury resorts and hospitality providers are embedding Traditional Chinese Medicine and Ayurvedic treatments into biohacking and longevity retreats, advancing beyond simple relaxation to offer evidence-based restorative care. This convergence attracts affluent travelers looking for proactive health optimization and immersive holistic experiences rather than reactive medical interventions. Reflecting this strong demand, the Global Wellness Institute's 'Global Wellness Economy Monitor 2025', released in December 2025, projects that the Traditional and Complementary Medicine sector will grow at an annual rate of 10.8% through 2029, significantly exceeding broader economic growth trends.

Key Market Players

  • Modern Acupuncture
  • Chiropuncture, Inc.
  • ARC Acupuncture & Physical Therapy
  • NatureKue, Inc.
  • Columbia Nutritional, LLC
  • Herb Pharm
  • HILLS HERBAL CARE
  • Pure Encapsulations Inc
  • Ayush Ayurveda
  • SHENG CHANG PHARMACEUTICAL CO., LTD.

Report Scope

In this report, the Global Botanicals & Acupuncture Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Botanicals & Acupuncture Market, By Intervention

  • Botanicals (Ayurveda, Naturopathy, Homeopathy)
  • Acupuncture

Botanicals & Acupuncture Market, By Distribution Method

  • Direct Sales
  • E-Sales
  • Distance Correspondence

Botanicals & Acupuncture Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Botanicals & Acupuncture Market.

Available Customizations:

Global Botanicals & Acupuncture Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Botanicals & Acupuncture Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Intervention (Botanicals (Ayurveda, Naturopathy, Homeopathy), Acupuncture)
    • 5.2.2. By Distribution Method (Direct Sales, E-Sales, Distance Correspondence)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Botanicals & Acupuncture Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Intervention
    • 6.2.2. By Distribution Method
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Botanicals & Acupuncture Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Intervention
        • 6.3.1.2.2. By Distribution Method
    • 6.3.2. Canada Botanicals & Acupuncture Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Intervention
        • 6.3.2.2.2. By Distribution Method
    • 6.3.3. Mexico Botanicals & Acupuncture Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Intervention
        • 6.3.3.2.2. By Distribution Method

7. Europe Botanicals & Acupuncture Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Intervention
    • 7.2.2. By Distribution Method
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Botanicals & Acupuncture Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Intervention
        • 7.3.1.2.2. By Distribution Method
    • 7.3.2. France Botanicals & Acupuncture Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Intervention
        • 7.3.2.2.2. By Distribution Method
    • 7.3.3. United Kingdom Botanicals & Acupuncture Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Intervention
        • 7.3.3.2.2. By Distribution Method
    • 7.3.4. Italy Botanicals & Acupuncture Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Intervention
        • 7.3.4.2.2. By Distribution Method
    • 7.3.5. Spain Botanicals & Acupuncture Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Intervention
        • 7.3.5.2.2. By Distribution Method

8. Asia Pacific Botanicals & Acupuncture Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Intervention
    • 8.2.2. By Distribution Method
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Botanicals & Acupuncture Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Intervention
        • 8.3.1.2.2. By Distribution Method
    • 8.3.2. India Botanicals & Acupuncture Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Intervention
        • 8.3.2.2.2. By Distribution Method
    • 8.3.3. Japan Botanicals & Acupuncture Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Intervention
        • 8.3.3.2.2. By Distribution Method
    • 8.3.4. South Korea Botanicals & Acupuncture Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Intervention
        • 8.3.4.2.2. By Distribution Method
    • 8.3.5. Australia Botanicals & Acupuncture Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Intervention
        • 8.3.5.2.2. By Distribution Method

9. Middle East & Africa Botanicals & Acupuncture Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Intervention
    • 9.2.2. By Distribution Method
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Botanicals & Acupuncture Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Intervention
        • 9.3.1.2.2. By Distribution Method
    • 9.3.2. UAE Botanicals & Acupuncture Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Intervention
        • 9.3.2.2.2. By Distribution Method
    • 9.3.3. South Africa Botanicals & Acupuncture Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Intervention
        • 9.3.3.2.2. By Distribution Method

10. South America Botanicals & Acupuncture Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Intervention
    • 10.2.2. By Distribution Method
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Botanicals & Acupuncture Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Intervention
        • 10.3.1.2.2. By Distribution Method
    • 10.3.2. Colombia Botanicals & Acupuncture Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Intervention
        • 10.3.2.2.2. By Distribution Method
    • 10.3.3. Argentina Botanicals & Acupuncture Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Intervention
        • 10.3.3.2.2. By Distribution Method

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Botanicals & Acupuncture Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Modern Acupuncture
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Chiropuncture, Inc.
  • 15.3. ARC Acupuncture & Physical Therapy
  • 15.4. NatureKue, Inc.
  • 15.5. Columbia Nutritional, LLC
  • 15.6. Herb Pharm
  • 15.7. HILLS HERBAL CARE
  • 15.8. Pure Encapsulations Inc
  • 15.9. Ayush Ayurveda
  • 15.10. SHENG CHANG PHARMACEUTICAL CO., LTD.

16. Strategic Recommendations

17. About Us & Disclaimer